TCM
ABBV icon

Tufton Capital Management’s AbbVie ABBV Stock Holding History

Tufton Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.5M Sell
53,477
-656
-1% -$141K 2.26% 10
2026
Q1 		$11.8M Sell
54,133
-959
-2% -$213K 2.14% 14
2025
Q4 		$12.6M Sell
55,092
-308
-0.6% -$70.2K 2.2% 12
2025
Q3 		$12.8M Buy
55,400
+175
+0.3% +$35.6K 2.29% 9
2025
Q2 		$10.3M Sell
55,225
-2,159
-4% -$401K 1.95% 12
2025
Q1 		$12M Sell
57,384
-779
-1% -$151K 2.32% 8
2024
Q4 		$10.3M Buy
58,163
+286
+0.5% +$52.6K 1.96% 13
2024
Q3 		$11.4M Sell
57,877
-1,032
-2% -$193K 2.14% 12
2024
Q2 		$10.1M Sell
58,909
-160
-0.3% -$26.5K 1.96% 15
2024
Q1 		$10.8M Sell
59,069
-391
-0.7% -$67.4K 2.11% 12
2023
Q4 		$9.21M Sell
59,460
-690
-1% -$101K 1.93% 14
2023
Q3 		$8.97M Sell
60,150
-222
-0.4% -$32.6K 2% 13
2023
Q2 		$8.13M Sell
60,372
-2,007
-3% -$294K 1.75% 23
2023
Q1 		$9.94M Sell
62,379
-10,596
-15% -$1.62M 2.15% 15
2022
Q4 		$11.8M Sell
72,975
-365
-0.5% -$56K 2.59% 7
2022
Q3 		$9.84M Sell
73,340
-37,389
-34% -$5.37M 2.38% 9
2022
Q2 		$17M Sell
110,729
-7,179
-6% -$1.1M 3.17% 3
2022
Q1 		$19.1M Sell
117,908
-3,227
-3% -$469K 3.09% 5
2021
Q4 		$16.4M Buy
121,135
+266
+0.2% +$31.4K 2.52% 7
2021
Q3 		$13M Sell
120,869
-2,153
-2% -$246K 2.21% 8
2021
Q2 		$13.9M Sell
123,022
-2,403
-2% -$271K 2.28% 8
2021
Q1 		$13.6M Buy
125,425
+4,870
+4% +$521K 2.32% 9
2020
Q4 		$12.9M Buy
120,555
+4,488
+4% +$431K 2.38% 10
2020
Q3 		$10.2M Buy
116,067
+65
+0.1% +$6.12K 2.1% 16
2020
Q2 		$11.4M Buy
116,002
+255
+0.2% +$22.5K 2.51% 10
2020
Q1 		$8.82M Buy
115,747
+171
+0.1% +$14.6K 2.26% 14
2019
Q4 		$10.2M Buy
115,576
+898
+0.8% +$74.6K 2.01% 17
2019
Q3 		$8.68M Sell
114,678
-9,061
-7% -$621K 1.83% 21
2019
Q2 		$9M Buy
123,739
+2,460
+2% +$193K 1.9% 21
2019
Q1 		$9.77M Buy
121,279
+6,500
+6% +$532K 2.08% 15
2018
Q4 		$10.6M Buy
114,779
+1,624
+1% +$143K 2.6% 7
2018
Q3 		$10.7M Sell
113,155
-6,372
-5% -$604K 2.28% 13
2018
Q2 		$11.1M Sell
119,527
-559
-0.5% -$54.6K 2.37% 7
2018
Q1 		$11.4M Sell
120,086
-4,418
-4% -$485K 2.24% 7
2017
Q4 		$12M Sell
124,504
-12,908
-9% -$1.22M 2.32% 6
2017
Q3 		$12.2M Sell
137,412
-1,173
-0.8% -$89.3K 2.44% 5
2017
Q2 		$10M Sell
138,585
-546
-0.4% -$36.7K 2.04% 11
2017
Q1 		$9.07M Buy
139,131
+30
+0% +$1.89K 1.79% 14
2016
Q4 		$8.71M Buy
139,101
+3,122
+2% +$191K 1.77% 14
2016
Q3 		$8.58M Buy
135,979
+1,255
+0.9% +$81.2K 1.73% 15
2016
Q2 		$8.34M Sell
134,724
-4,353
-3% -$265K 1.69% 16
2016
Q1 		$7.94M Buy
139,077
+3,511
+3% +$196K 1.98% 13
2015
Q4 		$8.03M Sell
135,566
-994
-0.7% -$57.3K 1.98% 15
2015
Q3 		$7.43M Sell
136,560
-4,729
-3% -$308K 1.63% 17
2015
Q2 		$9.49M Sell
141,289
-10,765
-7% -$703K 1.92% 13
2015
Q1 		$8.9M Buy
152,054
+38,821
+34% +$2.35M 1.63% 18
2014
Q4 		$7.41M Sell
113,233
-2,999
-3% -$189K 1.35% 25
2014
Q3 		$6.71M Sell
116,232
-1,070
-0.9% -$59.4K 1.26% 27
2014
Q2 		$6.62M Buy
117,302
+34,690
+42% +$1.82M 1.34% 29
2014
Q1 		$4.25M Buy
82,612
+5,940
+8% +$300K 0.89% 49
2013
Q4 		$4.05M Buy
76,672
+365
+0.5% +$17.9K 0.87% 49
2013
Q3 		$3.41M Sell
76,307
-286
-0.4% -$12.7K 0.8% 50
2013
Q2 		$3.17M Buy
+76,593
New +$3.35M 0.76% 53

Other funds holding ABBV

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Tufton Capital Management's ABBV Position: Q2 2026 in Review

Tufton Capital Management reduced its AbbVie (ABBV) stake by 1.2% in Q2 2026, selling an estimated $141K and leaving 53,477 shares worth $13.5M. The position accounts for 2.26% of the portfolio, ranked #10.

Tufton Capital Management first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $19.1M in Q1 2022. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Tufton Capital Management held 53,477 shares of AbbVie worth $13.5M as of Q2 2026.
  • Tufton Capital Management sold 656 AbbVie shares in Q2 2026, an estimated $141K.
  • AbbVie made up 2.26% of Tufton Capital Management's portfolio in Q2 2026, its #10 holding.
  • Tufton Capital Management first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • Tufton Capital Management's AbbVie position peaked at $19.1M in Q1 2022.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Tufton Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.